The CCB has been successful in securing over $1.3m in grants from The Hospital Research Foundation (THRF) in their inaugural Adelaide BioMed City Grant round. The CCB received 6 of the 15 grants awarded, with successful grants in each of the 5 grant categories.
Grants received by Prof Michael Brown and Dr David Ross will enable the CCB to build capacity in translational research through partnerships, strategic recruitment, involvement of clinicians in research activities and greater interaction between clinical and laboratory researchers.
Capitalising on this new funding stream will enhance the CCBs sustainability through diversity in funding sources and supplement the CCB’s successful performance in category 1 funding.
Successful grants include:
 |
Dr Peer Arts - 2 Year Early-Career Fellowship Characterising haematological malignancies through genetic and immunological evaluation |
 |
Dr Damon Tumes - 3 Year Mid-Career Fellowship Toward personalized medicine for allergic airway inflammation and harnessing allergic pathways to treat cancer |
 |
Prof Michael Brown, A/Prof David Ziegler and Dr Tessa Gargett - Translational Grant Clinical testing of new T-cell therapy for adult and paediatric patients with aggressive primary brain cancers |
 |
Dr David Ross, Prof Richard D/Andrea and Prof Angel Lopez - Project Grant A new immune therapy targeting the myelofibrosis stem cell with CD123 antibody treatment |
 |
Prof Sharad Kumar, Dr Jantina Manning and A/Prof John Finnie - Project Grant Dietary sodium as a modulator of kidney disease |
 |
Rhys Hamon - Postgraduate Scholarship The role of 14-3-3 protein in lung cancer initiation, progression and metastasis​ |
